• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Arthritis Center

Show Search
Hide Search
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
  • Patient Corner
    • Drug Information Sheets
    • Managing Your Arthritis
    • RheumTV – Patient Education Video Library
  • Our Research
    • Patient-Centered Outcomes Research
    • Current Research Studies
    • The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
    • News & Updates
  • Donate
Home / Ask the Expert / Are DMARDs Safe?

Are DMARDs Safe?

August 1, 2007 By Arthritis Center

Question

I am 35 years old now and was diagnosed with Reiter’s syndrome in 2003, hospiatlized with severe right sacroiliac pain. Presently I am on NSAIDs and short courses of prednisone to treat the flares. These worked until recently when my right sacroiliac joint and the surronding areas are stiff and hurt a lot. I want to go on long term treatment with one of the DMARDs, but am hesitant due to the side effects these might produce. How safe are these DMARDs in treating the disease and duration of use? Will I be able to go on them for 15 or 20 years without critically damaging my system? Are biologics better? I have read that biologocs can cause lymphoma and trigger other serious infections? Your response is greatly appreciated.

Answer

Make sure you look on this website for addtiional information.  In terms of effectiveness, traditional DMARDs such as methotrexate help the peripheral joints but likely do not help the symptoms of the spine such as sacroilitis.  Biologic agents the TNF inhibitors are the only medications effective for the spine beyond NSAIDs.  Long term trials and registries are still ongoing to answer the questions about safety of the biologic agents.  However, the information to date looks very promising that there will not be any significant long term side effects.  Etanercept (Enbrel) has reported 9 year long term data showing safety and effectiveness.  There is a slight increased risk of serious infections with TNF inhibitors.  Most studies have not shown an increase in lymphoma.

Arthritis Center

Founded in 1998, the Arthritis Center at Johns Hopkins is dedicated to providing quality education to patients and healthcare providers alike.

Primary Sidebar

Ask The Expert Topics

  • Alternative Therapies
  • Ankylosing Spondylitis
  • Associated With Other Illnesses
  • Bursitis and Tendinitis
  • Corticosteroids
  • Diet and Exercise
  • Disease Modifying Antirheumatic Drugs (DMARDs)
  • Enteropathic Arthritis
  • Fibromyalgia
  • General Arthritis
  • Gout, Pseudogout, Other
  • Infectious Arthritis
  • Myositis
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Osteoarthritis
  • Osteonecrosis
  • Osteoporosis
  • Polymyalgia Rheumatica
  • Psoriatic Arthritis
  • Reactive Arthritis
  • Regional Pain: Back and Neck
  • Rehabilitation
  • Rheumatoid Arthritis
  • Surgical Therapy
  • Systemic Lupus Erythematosus (SLE)
  • Systemic Sclerosis
  • Vasculitis
RheumTV Logo

Rheum.TV is an informational platform created to educate patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit Rheum.TV

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube

Johns Hopkins Medicine

© 2025 Johns Hopkins Arthritis Center
Patient Privacy